• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过FIC指数和时间杀菌曲线评估达托霉素与庆大霉素或β-内酰胺类抗生素对金黄色葡萄球菌和肠球菌的体外相互作用。

Evaluation of in vitro interaction of daptomycin with gentamicin or beta-lactam antibiotics against Staphylococcus aureus and Enterococci by FIC index and timed-kill curves.

作者信息

Snydman D R, McDermott L A, Jacobus N V

机构信息

Tufts-New England Medical Center, 750 Washington St., Boston, MA 02111, USA.

出版信息

J Chemother. 2005 Dec;17(6):614-21. doi: 10.1179/joc.2005.17.6.614.

DOI:10.1179/joc.2005.17.6.614
PMID:16433191
Abstract

The interactions of daptomycin with gentamicin and 5 beta-lactam agents were determined by checkerboard and timed-kill studies. Eighty isolates were tested by checkerboard: 20 each of methicillin-resistant Staphylococcus aureus (MRSA), methicillin-susceptible Staphylococcus aureus (MSSA), vancomycin-susceptible Enterococcus faecalis (VSEF) and vancomycin-resistant enterococci (VRE). Time kill curves were performed on 8 selected isolates: 2 each of MRSA, MSSA, VSEF and VRE. Checkerboard results showed highest frequency of synergistic effects against VSEF (35-75%) with daptomycin combined with ceftriaxone, cefepime or imipenem; a modest effect with most combinations against VRE and MRSA (5-20%); and indifference with daptomycin and most agents against MSSA (0-5%); except with daptomycin with oxacillin where 10-20% synergy was observed. Synergistic interaction was confirmed by time kill studies in seven of ten isolates where checkerboard suggested synergy. A bactericidal effect was exerted in 5/7 synergistic combinations. The in vitro data suggest that daptomycin combined with other antibiotics may be microbiologically beneficial and not antagonistic.

摘要

通过棋盘法和时间杀菌研究确定了达托霉素与庆大霉素及5种β-内酰胺类药物的相互作用。用棋盘法检测了80株菌株:耐甲氧西林金黄色葡萄球菌(MRSA)、甲氧西林敏感金黄色葡萄球菌(MSSA)、万古霉素敏感粪肠球菌(VSEF)和万古霉素耐药肠球菌(VRE)各20株。对8株选定的菌株进行了时间杀菌曲线实验:MRSA、MSSA、VSEF和VRE各2株。棋盘法结果显示,达托霉素与头孢曲松、头孢吡肟或亚胺培南联合使用时,对VSEF的协同效应频率最高(35%-75%);对大多数VRE和MRSA组合有中等效应(5%-20%);达托霉素与大多数药物对MSSA无相互作用(0%-5%);但达托霉素与苯唑西林联合使用时观察到10%-20%的协同作用。在棋盘法提示有协同作用的10株菌株中,有7株通过时间杀菌研究证实了协同相互作用。在5/7的协同组合中发挥了杀菌作用。体外数据表明,达托霉素与其他抗生素联合使用可能在微生物学上有益且无拮抗作用。

相似文献

1
Evaluation of in vitro interaction of daptomycin with gentamicin or beta-lactam antibiotics against Staphylococcus aureus and Enterococci by FIC index and timed-kill curves.通过FIC指数和时间杀菌曲线评估达托霉素与庆大霉素或β-内酰胺类抗生素对金黄色葡萄球菌和肠球菌的体外相互作用。
J Chemother. 2005 Dec;17(6):614-21. doi: 10.1179/joc.2005.17.6.614.
2
Serum bactericidal activities of high-dose daptomycin with and without coadministration of gentamicin against isolates of Staphylococcus aureus and Enterococcus species.高剂量达托霉素联合或不联合庆大霉素对金黄色葡萄球菌和肠球菌分离株的血清杀菌活性。
Antimicrob Agents Chemother. 2006 Nov;50(11):3529-34. doi: 10.1128/AAC.00290-06.
3
Synergy of daptomycin with oxacillin and other beta-lactams against methicillin-resistant Staphylococcus aureus.达托霉素与苯唑西林及其他β-内酰胺类药物联合对耐甲氧西林金黄色葡萄球菌的协同作用。
Antimicrob Agents Chemother. 2004 Aug;48(8):2871-5. doi: 10.1128/AAC.48.8.2871-2875.2004.
4
Oritavancin Combinations with β-Lactams against Multidrug-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci.奥利万星与β-内酰胺类药物联合用于对抗耐多药金黄色葡萄球菌和耐万古霉素肠球菌
Antimicrob Agents Chemother. 2016 Mar 25;60(4):2352-8. doi: 10.1128/AAC.03006-15. Print 2016 Apr.
5
Time-kill kinetics of oritavancin and comparator agents against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium.奥利万星及对照药物对金黄色葡萄球菌、粪肠球菌和屎肠球菌的时间杀菌动力学
J Antimicrob Chemother. 2009 Jun;63(6):1191-9. doi: 10.1093/jac/dkp126. Epub 2009 Apr 15.
6
Short-course gentamicin in combination with daptomycin or vancomycin against Staphylococcus aureus in an in vitro pharmacodynamic model with simulated endocardial vegetations.在具有模拟心内膜赘生物的体外药效学模型中,短疗程庆大霉素联合达托霉素或万古霉素治疗金黄色葡萄球菌感染
Antimicrob Agents Chemother. 2005 Jul;49(7):2735-45. doi: 10.1128/AAC.49.7.2735-2745.2005.
7
Comparative bactericidal activities of daptomycin, glycopeptides, linezolid and tigecycline against blood isolates of Gram-positive bacteria in Taiwan.台湾地区达托霉素、糖肽类、利奈唑胺和替加环素对革兰氏阳性菌血液分离株的杀菌活性比较
Clin Microbiol Infect. 2008 Feb;14(2):124-9. doi: 10.1111/j.1469-0691.2007.01888.x. Epub 2007 Dec 10.
8
In vitro activity of daptomycin alone and in combination with various antimicrobials against Gram-positive cocci.达托霉素单独及与多种抗菌药物联合对革兰氏阳性球菌的体外活性。
J Chemother. 2006 Feb;18(1):27-32. doi: 10.1179/joc.2006.18.1.27.
9
In vitro activity of nemonoxacin (TG-873870), a novel non-fluorinated quinolone, against clinical isolates of Staphylococcus aureus, enterococci and Streptococcus pneumoniae with various resistance phenotypes in Taiwan.在台湾,对具有不同耐药表型的金黄色葡萄球菌、肠球菌和肺炎链球菌的临床分离株进行体外药敏试验,评估新型非氟喹诺酮类药物奈莫沙星(TG-873870)的抗菌活性。
J Antimicrob Chemother. 2009 Dec;64(6):1226-9. doi: 10.1093/jac/dkp370. Epub 2009 Oct 14.
10
identification of underutilized β-lactam combinations against methicillin-resistant bacteremia isolates.针对耐甲氧西林菌血症分离株未充分利用的β-内酰胺类联合用药的鉴定。
Microbiol Spectr. 2024 Aug 6;12(8):e0097624. doi: 10.1128/spectrum.00976-24. Epub 2024 Jun 25.

引用本文的文献

1
Antibiotic synergy against : a systematic review and meta-analysis.抗生素协同作用:一项系统评价与荟萃分析
Antimicrob Agents Chemother. 2025 Aug 6;69(8):e0119924. doi: 10.1128/aac.01199-24. Epub 2025 Jun 17.
2
Comparison of efficacy and safety between daptomycin plus β-lactam and daptomycin monotherapy for bloodstream infections due to gram-positive cocci: A systematic review and meta-analysis.达托霉素联合β-内酰胺类药物与达托霉素单药治疗革兰氏阳性球菌血流感染的疗效和安全性比较:一项系统评价和荟萃分析。
Heliyon. 2024 Apr 16;10(8):e29811. doi: 10.1016/j.heliyon.2024.e29811. eCollection 2024 Apr 30.
3
Enhancing Antibiotics Efficacy by Combination of Kuraridin and Epicatechin Gallate with Antimicrobials against Methicillin-Resistant .
通过苦石蒜碱和表没食子儿茶素没食子酸酯与抗菌药物联合使用增强对耐甲氧西林菌的抗生素疗效
Antibiotics (Basel). 2023 Jan 8;12(1):117. doi: 10.3390/antibiotics12010117.
4
Does a New Antibiotic Scheme Improve the Outcome of -Caused Acute Prosthetic Joint Infections (PJI) Treated with Debridement, Antibiotics and Implant Retention (DAIR)?一种新的抗生素方案能否改善清创、抗生素治疗和保留植入物(DAIR)治疗的由[具体病因未提及]引起的急性人工关节感染(PJI)的预后?
Antibiotics (Basel). 2022 Jul 8;11(7):922. doi: 10.3390/antibiotics11070922.
5
Verification of a Novel Approach to Predicting Effects of Antibiotic Combinations: In Vitro Dynamic Model Study with Daptomycin and Gentamicin against .一种预测抗生素联合用药效果的新方法的验证:达托霉素和庆大霉素对……的体外动力学模型研究
Antibiotics (Basel). 2020 Aug 25;9(9):538. doi: 10.3390/antibiotics9090538.
6
The Antistaphylococcal Activity of Amoxicillin/Clavulanic Acid, Gentamicin, and 1,8-Cineole Alone or in Combination and Their Efficacy through a Rabbit Model of Methicillin-Resistant Osteomyelitis.阿莫西林/克拉维酸、庆大霉素和1,8-桉叶素单独或联合使用的抗葡萄球菌活性及其通过耐甲氧西林骨髓炎兔模型的疗效。
Evid Based Complement Alternat Med. 2020 Apr 28;2020:4271017. doi: 10.1155/2020/4271017. eCollection 2020.
7
A study on combination of daptomycin with selected antimicrobial agents: in vitro synergistic effect of MIC value of 1 mg/L against MRSA strains.一项关于达托霉素与选定抗菌药物联合使用的研究:对 MRSA 菌株的 MIC 值为 1mg/L 时的体外协同作用。
BMC Pharmacol Toxicol. 2019 May 6;20(1):25. doi: 10.1186/s40360-019-0305-y.
8
Daptomycin versus placebo as an adjunct to beta-lactam therapy in the treatment of Staphylococcus aureus bacteremia: study protocol for a randomized controlled trial.达托霉素与安慰剂作为β-内酰胺类治疗金黄色葡萄球菌菌血症的辅助药物:一项随机对照试验的研究方案
Trials. 2018 May 29;19(1):297. doi: 10.1186/s13063-018-2668-6.
9
CAMERA2 - combination antibiotic therapy for methicillin-resistant Staphylococcus aureus infection: study protocol for a randomised controlled trial.CAMERA2 - 耐甲氧西林金黄色葡萄球菌感染的联合抗生素治疗:一项随机对照试验的研究方案
Trials. 2016 Mar 31;17:170. doi: 10.1186/s13063-016-1295-3.
10
Daptomycin-Nonsusceptible Staphylococcus aureus: The Role of Combination Therapy with Daptomycin and Gentamicin.达托霉素不敏感金黄色葡萄球菌:达托霉素与庆大霉素联合治疗的作用
Genes (Basel). 2015 Nov 30;6(4):1256-67. doi: 10.3390/genes6041256.